If you were unable to join us for our community meeting at NBC, we're sorry we missed you.
Attached is the presentation that was shared as well as a link to a very short survey to help us understand how biomarker assay qualifications and validations are defined and used at your company. Please complete the survey if you can by June 15, 2025.
https://www.surveymonkey.com/r/QH2BRWL" href="https://www.surveymonkey.com/r/QH2BRWL" rel="noreferrer noopener" target="_blank" class="fui-Link ___1q1shib f2hkw1w f3rmtva f1ewtqcl fyind8e f1k6fduh f1w7gpdv fk6fouc fjoy568 figsok6 f1s184ao f1mk8lai fnbmjn9 f1o700av f13mvf36 f1cmlufx f9n3di6 f1ids18y f1tx3yz7 f1deo86v f1eh06m1 f1iescvh fhgqx19 f1olyrje f1p93eir f1nev41a f1h8hb77 f1lqvz6u f10aw75t fsle3fq f17ae5zn" title="https://www.surveymonkey.com/r/qh2brwl">https://www.surveymonkey.com/r/QH2BRWL
Thanks!
------------------------------
Jennifer Vance Ph.D.
Dir. of Bioanalytical and Biomarker Development
Recursion Pharmaceuticals
Salt Lake City UT
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------